Headache News and Research

Latest Headache News and Research

FDA grants approval for first breast cancer drug through 'Real-Time Oncology Review'

The U.S. Food and Drug Administration today approved Kisqali (ribociclib) in combination with an aromatase inhibitor for the treatment of pre/perimenopausal or postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer, as initial endocrine-based therapy.

19 Jul 2018

Researchers find that yellow fever and Asian tiger mosquitoes can carry new virus

A virus responsible for an illness outbreak in Venezuela is spreading to other parts of the Americas, says a University of Florida scientist who is closely monitoring the Mayaro virus.

18 Jul 2018

Pre-clinical pilot study shows promising results of 'concussion pill'

In 2016, funded by a $16 million grant from Scythian, the multidisciplinary Miller School team embarked on a five-year study to examine the effects of combining CBD (a cannabinoid derivative of hemp) with an NMDA antagonist (an anesthetic used in animals and humans) for the treatment of traumatic brain injury and concussion.

16 Jul 2018

Parents struggle with what to do when their child has headache, shows study

Parents sometimes struggle with what to do when their child has a headache: go to the ER, to the doctor, or wait it out at home, a new national poll suggests.

16 Jul 2018

Researchers describe key role of enzyme in regulating immune response against Chagas disease parasite

In an article published recently in the journal Nature Communications, researchers affiliated with the University of São Paulo in Brazil describe the central role played by an enzyme called phosphatidylinositol 3-kinase gamma in regulating the immune response against Trypanosoma cruzi, the protozoan parasite that causes Chagas disease.

16 Jul 2018

Delivery of thrombolytic treatment for stroke in Helsinki beats expectations

Neurologists around the world are aware that the delivery of thrombolytic treatment for stroke in Helsinki University Hospital, Finland, is freaking fast - but is it too fast?

13 Jul 2018

Researchers design artificial intelligence system for predicting drug combinations' side effects

Last month alone, 23 percent of Americans took two or more prescription drugs, according to one CDC estimate, and 39 percent over age 65 take five or more, a number that's increased three-fold in the last several decades.

10 Jul 2018

NIH researchers identify natural lipid that acts as potent anti-inflammatory

National Institutes of Health researchers have identified a naturally occurring lipid--a waxy, fatty acid--used by a disease-causing bacterium to impair the host immune response and increase the chance of infection. Inadvertently, they also may have found a potent inflammation therapy against bacterial and viral diseases.

9 Jul 2018

Smartphone headache apps pose privacy risks, study finds

Headache diaries are a mainstay of migraine management, and many commercial smartphone apps have been developed to help people track their pain.

5 Jul 2018

Zika virus-related pregnancy loss in humans may be more common than thought

Fetal death in utero occurred in more than one-fourth of monkeys infected in the laboratory with Zika virus in early pregnancy, according to new research published in Nature Medicine.

3 Jul 2018

PMDA approves use of LYNPARZA in patients with BRCA-mutated breast cancer

AstraZeneca and Merck, known as MSD outside the United States and Canada, today announced that Japan's Pharmaceuticals and Medical Devices Agency has approved LYNPARZA tablets for use in patients with unresectable or recurrent BRCA-mutated, human epidermal growth factor receptor 2 -negative breast cancer who have received prior chemotherapy.

2 Jul 2018

Neurologist suggests maintaining a headache diary to determine and avoid migraine triggers

If you've ever had a migraine, you know it's different from a typical tension headache. A migraine is a type of headache that comes with its own set of symptoms like nausea, sensitivity to light, sound or smells, extreme fatigue or dizziness.

30 Jun 2018

Psychologist suggests few guidelines on how to help children handle scary news

When tragic or violent events occur, parents may wonder about how to help their kids understand the graphic images and emotional video footage that they may see. Stephanie Marcy, PhD, psychologist at Children's Hospital Los angeles suggests a few guidelines to keep in mind so parents can be better equipped to help their children handle scary news.

28 Jun 2018

Researchers identify electrical activity in the brain specific to the start of migraine

When migraine sufferers see the tell-tale squiggly lines, light flashes and blind spots of a migraine aura, they prepare for a migraine.

27 Jun 2018

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has accepted for standard review a new supplemental Biologics License Application for KEYTRUDA, Merck's anti-PD-1 therapy, as adjuvant therapy in the treatment of patients with resected, high-risk stage III melanoma and granted a Prescription Drug User Fee Act, or target action, date of February 16, 2019.

25 Jun 2018

Alcohol hangovers more significant and costly than people realize, shows research

Alcohol hangovers are more significant and costly than people realize, new research shows. Although individuals may be "street legal" to drive a car, or go to work and operate machinery, they can be just as impaired with a hangover as if they were over the alcohol limit.

20 Jun 2018

Study shows how moderate consumption of alcohol can protect the heart

For at least 20 years, research has shown that for many people, moderate consumption of alcohol can protect the heart, but the reason for this is poorly understood.

18 Jun 2018

New study focuses on best, cost effective practices to bridge treatment gap for brain disorders

Up to eight out of ten patients with a brain disorder remain untreated or inadequately treated. But what is the best practice - and above all, most cost effective - healthcare interventions to bridge the treatment gap? This was the focus of the European Brain Council's study entitled The Value of Treatment which was discussed at the Congress of the European Academy of Neurology in Lisbon.

18 Jun 2018

Alnylam announces new positive results from Phase 1/2 study of lumasiran in patients with PH1

Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today new positive results from its Phase 1/2 study with lumasiran, an investigational RNAi therapeutic targeting glycolate oxidase for the treatment of Primary Hyperoxaluria Type 1.

8 Jun 2018

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Bristol-Myers Squibb Company today announced patient-reported outcomes data from the Phase 3 CheckMate -214 trial in intermediate- and poor-risk patients with advanced renal cell carcinoma treated with the Immuno-Oncology combination Opdivo plus low-dose Yervoy versus sunitinib over a two-year follow-up period.

1 Jun 2018

Headache News and Research

Latest Headache News and Research

FDA grants approval for first breast cancer drug through 'Real-Time Oncology Review'

Researchers find that yellow fever and Asian tiger mosquitoes can carry new virus

Pre-clinical pilot study shows promising results of 'concussion pill'

Parents struggle with what to do when their child has headache, shows study

Researchers describe key role of enzyme in regulating immune response against Chagas disease parasite

Delivery of thrombolytic treatment for stroke in Helsinki beats expectations

Researchers design artificial intelligence system for predicting drug combinations' side effects

NIH researchers identify natural lipid that acts as potent anti-inflammatory

Smartphone headache apps pose privacy risks, study finds

Zika virus-related pregnancy loss in humans may be more common than thought

PMDA approves use of LYNPARZA in patients with BRCA-mutated breast cancer

Neurologist suggests maintaining a headache diary to determine and avoid migraine triggers

Psychologist suggests few guidelines on how to help children handle scary news

Researchers identify electrical activity in the brain specific to the start of migraine

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Alcohol hangovers more significant and costly than people realize, shows research

Study shows how moderate consumption of alcohol can protect the heart

New study focuses on best, cost effective practices to bridge treatment gap for brain disorders

Alnylam announces new positive results from Phase 1/2 study of lumasiran in patients with PH1

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Headache News and Research

Latest Headache News and Research

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in